GPED Regimen for Relapsed/Refractory or Advanced ENKTCL

Clinical trial NCT04405375 · UNKNOWN

Trial details

NCT number: NCT04405375
Sponsor: Beijing Tongren Hospital
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Extranodal NK/T-cell Lymphoma, Nasal Type

Start date: 2020-03-21
Primary completion: 2023-04-30
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.